IS2775B - Sambrædd pýrrólókarbasól og aðferðir við framleiðslu þeirra - Google Patents

Sambrædd pýrrólókarbasól og aðferðir við framleiðslu þeirra

Info

Publication number: IS2775B
Authority: IS; Iceland
Prior art keywords: pyrrolocarbazole; synthesized; production methods; production; methods
Prior art date: 2003-12-23

Application number

IS8520A

Other languages

English (en)

Icelandic (is)

Other versions

IS8520A (is

Inventor

Robert L Hudkins

Dandu R Reddy

Ming Tao

Theodore L Underiner

Allison L Zulli

Original Assignee

Cephalon Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2003-12-23

Filing date

2006-06-22

Publication date

2012-03-15

2006-06-22 Application filed by Cephalon Inc filed Critical Cephalon Inc

2006-06-22 Publication of IS8520A publication Critical patent/IS8520A/xx

2012-03-15 Publication of IS2775B publication Critical patent/IS2775B/is

Links

238000004519 manufacturing process Methods 0.000 title 1
QNMMYUBZGLXCCK-UHFFFAOYSA-N pyrrolo[3,2-a]carbazole Chemical compound N1=C2C=CC=CC2=C2C1=C1C=CN=C1C=C2 QNMMYUBZGLXCCK-UHFFFAOYSA-N 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
- C07D487/14—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains three hetero rings
- C07D513/14—Ortho-condensed systems
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09B—ORGANIC DYES OR CLOSELY-RELATED COMPOUNDS FOR PRODUCING DYES, e.g. PIGMENTS; MORDANTS; LAKES
- C09B57/00—Other synthetic dyes of known constitution
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09B—ORGANIC DYES OR CLOSELY-RELATED COMPOUNDS FOR PRODUCING DYES, e.g. PIGMENTS; MORDANTS; LAKES
- C09B57/00—Other synthetic dyes of known constitution
- C09B57/08—Naphthalimide dyes; Phthalimide dyes

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Medicinal Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical Kinetics & Catalysis (AREA)
Engineering & Computer Science (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Diabetes (AREA)
Physical Education & Sports Medicine (AREA)
Hematology (AREA)
Endocrinology (AREA)
Rheumatology (AREA)
Urology & Nephrology (AREA)
Orthopedic Medicine & Surgery (AREA)
Pain & Pain Management (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Dermatology (AREA)
Psychology (AREA)
Epidemiology (AREA)
Emergency Medicine (AREA)
Hospice & Palliative Care (AREA)
Psychiatry (AREA)
Pulmonology (AREA)
Ophthalmology & Optometry (AREA)
Oncology (AREA)
Obesity (AREA)
Immunology (AREA)
Vascular Medicine (AREA)

IS8520A 2003-12-23 2006-06-22 Sambrædd pýrrólókarbasól og aðferðir við framleiðslu þeirra IS2775B (is)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US53225203P	2003-12-23	2003-12-23
US11/017,915 US7241779B2 (en)	2003-12-23	2004-12-22	Fused pyrrolocarbazoles
PCT/US2004/043164 WO2005063764A2 (en)	2003-12-23	2004-12-23	Fused pyrrolocarbazoles and methods for the preparation thereof

Publications (2)

Publication Number	Publication Date
IS8520A IS8520A (is)	2006-06-22
IS2775B true IS2775B (is)	2012-03-15

Family

ID=34680997

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IS8520A IS2775B (is)	2003-12-23	2006-06-22	Sambrædd pýrrólókarbasól og aðferðir við framleiðslu þeirra

Country Status (21)

Country	Link
US (3)	US7241779B2 (pt)
EP (2)	EP1711499B1 (pt)
JP (1)	JP5006047B2 (pt)
KR (2)	KR101268704B1 (pt)
CN (2)	CN104788459A (pt)
AR (1)	AR048808A1 (pt)
AT (1)	ATE433453T1 (pt)
AU (1)	AU2004309397B2 (pt)
BR (1)	BRPI0418120A (pt)
CA (1)	CA2549628C (pt)
DE (1)	DE602004021508D1 (pt)
EA (1)	EA013182B1 (pt)
ES (2)	ES2326225T3 (pt)
IL (1)	IL176385A (pt)
IS (1)	IS2775B (pt)
MY (2)	MY142713A (pt)
NO (2)	NO336892B1 (pt)
NZ (1)	NZ586306A (pt)
SG (1)	SG149042A1 (pt)
TW (1)	TWI342309B (pt)
WO (1)	WO2005063764A2 (pt)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20060276497A1 (en) *	2000-05-09	2006-12-07	Cephalon, Inc.	Novel multicyclic compounds and the use thereof
US7241779B2 (en) *	2003-12-23	2007-07-10	Cephalon, Inc.	Fused pyrrolocarbazoles
US7169802B2 (en) *	2003-12-23	2007-01-30	Cephalon, Inc.	Fused pyrrolocarbazoles
US20060058250A1 (en) *	2004-09-10	2006-03-16	Cephalon, Inc.	Methods of treating proliferative skin diseases using carbazole derivatives
EP1869141B1 (de) *	2005-04-14	2020-03-11	Merck Patent GmbH	Verbindungen für organische elektronische vorrichtungen
US20060293378A1 (en) *	2005-06-28	2006-12-28	Mcintire Gregory	Method of lowering intraocular pressure
WO2008151323A1 (en) *	2007-06-08	2008-12-11	University Of Massachusetts	Mixed lineage kinases and metabolic disorders
TWI468417B (zh)	2007-11-30	2015-01-11	Genentech Inc	抗－ｖｅｇｆ抗體
US8609730B2 (en) *	2008-01-08	2013-12-17	The Trustees Of The University Of Pennsylvania	Rel inhibitors and methods of use thereof
WO2009158432A2 (en)	2008-06-27	2009-12-30	Amgen Inc.	Ang-2 inhibition to treat multiple sclerosis
AU2015202365B2 (en) *	2008-10-22	2016-11-24	Genentech, Inc.	Modulation of axon degeneration
CA2741089A1 (en)	2008-10-22	2010-04-29	Genentech, Inc.	Modulation of axon degeneration
CN103965204B (zh) *	2008-11-19	2016-09-07	赛福伦公司	吲唑并[5,4-a]吡咯并[3,4-c]咔唑化合物的新形式
SG10201406763WA (en) *	2009-10-22	2014-11-27	Genentech Inc	Modulation of axon degeneration
KR102013465B1 (ko) *	2011-04-13	2019-08-22	메르크 파텐트 게엠베하	전자 소자용 화합물
WO2013041599A1 (en) *	2011-09-21	2013-03-28	Givaudan Sa	Pyridine derivates and their use as umami tastants
KR20150124954A (ko) *	2013-02-28	2015-11-06	제넨테크, 인크.	Dlk 안정성을 조절하는 방법
US9029565B1 (en) *	2013-11-20	2015-05-12	Transitions Optical, Inc.	Fused ring indeno compounds for preparation of photochromic compounds
CN106715440B (zh) *	2015-04-21	2019-02-22	江苏恒瑞医药股份有限公司	咪唑并异吲哚类衍生物、其制备方法及其在医药上的应用
JP6501993B1 (ja)	2018-06-06	2019-04-17	三菱電機株式会社	プロセスバス適用保護システムおよびインテリジェント電子デバイス

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
NZ245203A (en) *	1991-11-29	1997-07-27	Banyu Pharma Co Ltd	5h-indolo[2,3-a]pyrrolo[3,4-c]carbazole-5,7(6h)-dione derivatives substituted in position-13 by a pentose or hexose group; corresponding indolo-furano(anhydride)intermediates
US5475110A (en) *	1994-10-14	1995-12-12	Cephalon, Inc.	Fused Pyrrolocarbazoles
US5594009A (en) *	1994-10-14	1997-01-14	Cephalon, Inc.	Fused pyrrolocarbazoles
US5591855A (en) *	1994-10-14	1997-01-07	Cephalon, Inc.	Fused pyrrolocarbazoles
US5705511A (en) *	1994-10-14	1998-01-06	Cephalon, Inc.	Fused pyrrolocarbazoles
US5616724A (en) *	1996-02-21	1997-04-01	Cephalon, Inc.	Fused pyrrolo[2,3-c]carbazole-6-ones
BR9711306A (pt)	1996-08-22	1999-08-17	Bristol Myers Squibb Co	Amino a-Úcar citotÄxico e derivados de a-Úcar correlatos de indolopirrolocarbazÄis
US6127401A (en) *	1998-06-05	2000-10-03	Cephalon, Inc.	Bridged indenopyrrolocarbazoles
US6200968B1 (en) *	1998-08-06	2001-03-13	Cephalon, Inc.	Particle-forming compositions containing fused pyrrolocarbazoles
US6841567B1 (en)	1999-02-12	2005-01-11	Cephalon, Inc.	Cyclic substituted fused pyrrolocarbazoles and isoindolones
US6630500B2 (en) *	2000-08-25	2003-10-07	Cephalon, Inc.	Selected fused pyrrolocarbazoles
US7109229B2 (en) *	2000-09-29	2006-09-19	Eli Lilly And Company	Methods and compounds for treating proliferative diseases
US6653290B2 (en)	2000-10-06	2003-11-25	Bristol-Myers Squibb Company	Tumor proliferation inhibitors
US6610727B2 (en)	2000-10-06	2003-08-26	Bristol-Myers Squibb Company	Anhydro sugar derivatives of indolocarbazoles
US6558420B2 (en)	2000-12-12	2003-05-06	Bausch & Lomb Incorporated	Durable flexible attachment components for accommodating intraocular lens
US7018999B2 (en)	2001-05-16	2006-03-28	Cephalon, Inc.	Methods for the treatment and prevention of pain
EP1697616B1 (en)	2003-10-28	2008-10-22	Daniel Warren	Method for reparing in-ground tunnel structures
US7241779B2 (en)	2003-12-23	2007-07-10	Cephalon, Inc.	Fused pyrrolocarbazoles
US7169802B2 (en) *	2003-12-23	2007-01-30	Cephalon, Inc.	Fused pyrrolocarbazoles

2004
- 2004-12-22 US US11/017,915 patent/US7241779B2/en not_active Expired - Lifetime
- 2004-12-23 JP JP2006547325A patent/JP5006047B2/ja not_active Expired - Lifetime
- 2004-12-23 MY MYPI20045330A patent/MY142713A/en unknown
- 2004-12-23 ES ES04820922T patent/ES2326225T3/es not_active Expired - Lifetime
- 2004-12-23 EA EA200601219A patent/EA013182B1/ru not_active IP Right Cessation
- 2004-12-23 TW TW093140223A patent/TWI342309B/zh not_active IP Right Cessation
- 2004-12-23 DE DE602004021508T patent/DE602004021508D1/de not_active Expired - Lifetime
- 2004-12-23 CN CN201510129906.8A patent/CN104788459A/zh active Pending
- 2004-12-23 AU AU2004309397A patent/AU2004309397B2/en not_active Ceased
- 2004-12-23 WO PCT/US2004/043164 patent/WO2005063764A2/en not_active Ceased
- 2004-12-23 EP EP04820922A patent/EP1711499B1/en not_active Expired - Lifetime
- 2004-12-23 EP EP09075214A patent/EP2088150B1/en not_active Expired - Lifetime
- 2004-12-23 BR BRPI0418120-4A patent/BRPI0418120A/pt not_active Application Discontinuation
- 2004-12-23 KR KR1020127011222A patent/KR101268704B1/ko not_active Expired - Fee Related
- 2004-12-23 CN CN201510655573.2A patent/CN105294702A/zh active Pending
- 2004-12-23 ES ES09075214T patent/ES2387596T3/es not_active Expired - Lifetime
- 2004-12-23 SG SG200809397-3A patent/SG149042A1/en unknown
- 2004-12-23 NZ NZ586306A patent/NZ586306A/en not_active IP Right Cessation
- 2004-12-23 AT AT04820922T patent/ATE433453T1/de not_active IP Right Cessation
- 2004-12-23 KR KR1020067014797A patent/KR20060126738A/ko not_active Ceased
- 2004-12-23 CA CA2549628A patent/CA2549628C/en not_active Expired - Fee Related
- 2004-12-23 MY MYPI20085251A patent/MY149041A/en unknown
- 2004-12-27 AR ARP040104891A patent/AR048808A1/es not_active Application Discontinuation
2006
- 2006-06-18 IL IL176385A patent/IL176385A/en active IP Right Grant
- 2006-06-22 IS IS8520A patent/IS2775B/is unknown
- 2006-07-10 NO NO20063193A patent/NO336892B1/no not_active IP Right Cessation
2007
- 2007-05-03 US US11/744,030 patent/US7514440B2/en not_active Expired - Lifetime
2009
- 2009-03-31 US US12/415,525 patent/US8084472B2/en not_active Expired - Lifetime
2015
- 2015-09-23 NO NO20151246A patent/NO338804B1/no not_active IP Right Cessation

Also Published As

Publication number	Publication date
TW200530244A (en)	2005-09-16
NO20151246L (no)	2006-09-15
US20070203135A1 (en)	2007-08-30
ATE433453T1 (de)	2009-06-15
MY142713A (en)	2010-12-31
KR101268704B1 (ko)	2013-05-28
MY149041A (en)	2013-07-15
IL176385A (en)	2014-02-27
EA013182B1 (ru)	2010-02-26
KR20120065433A (ko)	2012-06-20
DE602004021508D1 (de)	2009-07-23
NO20063193L (no)	2006-09-15
US8084472B2 (en)	2011-12-27
EP1711499A2 (en)	2006-10-18
BRPI0418120A (pt)	2007-04-27
EP2088150B1 (en)	2012-06-06
HK1096394A1 (en)	2007-06-01
NO336892B1 (no)	2015-11-23
US7241779B2 (en)	2007-07-10
CN104788459A (zh)	2015-07-22
IS8520A (is)	2006-06-22
AU2004309397A1 (en)	2005-07-14
CA2549628A1 (en)	2005-07-14
TWI342309B (en)	2011-05-21
EA200601219A1 (ru)	2006-12-29
HK1137439A1 (en)	2010-07-30
NO338804B1 (no)	2016-10-24
US20090186888A1 (en)	2009-07-23
AU2004309397B2 (en)	2011-05-19
WO2005063764A3 (en)	2005-08-25
ES2326225T3 (es)	2009-10-05
NZ586306A (en)	2011-12-22
CA2549628C (en)	2012-12-11
US20050137245A1 (en)	2005-06-23
JP5006047B2 (ja)	2012-08-22
EP1711499B1 (en)	2009-06-10
US7514440B2 (en)	2009-04-07
KR20060126738A (ko)	2006-12-08
JP2007526909A (ja)	2007-09-20
EP2088150A1 (en)	2009-08-12
IL176385A0 (en)	2006-10-05
WO2005063764A2 (en)	2005-07-14
CN105294702A (zh)	2016-02-03
AR048808A1 (es)	2006-05-31
ES2387596T3 (es)	2012-09-26
SG149042A1 (en)	2009-01-29

Publication	Publication Date	Title
IS8520A (is)	2006-06-22	Sambrædd pýrrólókarbasól og aðferðir við framleiðslu þeirra
NO20031776L (no)	2003-10-20	Null-boringskomplettering og produksjonssystem
DE60324888D1 (de)	2009-01-08	und Herstellungsverfahren
NO20032220D0 (no)	2003-05-15	Löfteverktöy II og fremgangsmåte for anvendelse av samme
IS8305A (is)	2006-02-16	Bindandi smíðar og aðferðir við notkun þeirra
DK1465615T3 (da)	2012-11-12	Tricykliske bisenonderivater og fremgangsmåder til anvendelse heraf
DK1591446T3 (da)	2013-06-10	Thienopyrimidinforbindelser og anvendelse deraf.
IL176089A0 (en)	2006-10-05	Modified macromolecules and methods of making and using thereof
NO20055211D0 (no)	2005-11-04	Anti-fungale forbindelser og fremgangsmater for anvendelse
IS7467A (is)	2004-09-23	Lansóprasólfjölgervingar og aðferðir við að framleiða þá
ATE512148T1 (de)	2011-06-15	Pyrazolo- und imidazopyrimidinderivate
DK1771421T3 (da)	2009-07-13	N-hydroxyamidderivater og anvendelse deraf
SI1743076T1 (sl)	2013-03-29	Akustiäśni elementi in njihova proizvodnja
NO20054095D0 (no)	2005-09-02	Pyridyloksymetyl og benzioksazolazabicyklisk derivater
EP1639096A4 (en)	2007-09-05	PROCESS FOR THE PRODUCTION OF NEURONES
DE60302757T2 (de)	2006-06-14	Kleinfahrzeug
IS7980A (is)	2005-08-12	Díarýlmetýlídenpíperidínafleiður, framleiðsla þeirra og notkun
IS8489A (is)	2006-05-26	Umritunarstillar og aðferðir þeirra
DE60322747D1 (de)	2008-09-18	Planare mehrkeulenantenne und herstellungsverfahren
DK1408059T3 (da)	2014-07-28	Latex og fremstilling heraf
GB0313617D0 (en)	2003-07-16	Transparent conducting structures and methods of production
FI20035185A0 (fi)	2003-10-17	Menetelmä ja laitteisto turvetuotannossa
NO20041050L (no)	2004-09-15	Fremgmgsmate og sammensetninger
FR2858986B3 (fr)	2005-07-22	Tamis
FI20030130A0 (fi)	2003-01-29	Seulontamenetelmä